Clinical Trial

Personalized Ventilator Settings for Patients on ECMO

Study acronym: PEEPECMO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
While mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS). Using extracorporeal membrane oxygenation (ECMO), the highest level of life support also known as the heart-lung machine, investigators may minimize injury from mechanical ventilation to allow the lungs to heal; however, the optimal ventilator strategies while on ECMO are unknown. This study will evaluate personalized ventilator strategy compared to standard of care ventilation.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-08-07
Trial Details
NCT Number NCT07673250
Lead Sponsor University of California, San Diego
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation, Respiratory Failure Patients Treated With ECMO, Respiratory Failure, ICU, Ventilator Induced Lung Injury
Enrollment 62 participants
Start Date 2026-09-01
Primary Completion 2030-06-30 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-06